IbisVision, the groundbreaking Glasgow company whose platform allows opticians to perform remote eye tests with patients in any location, has created a new role of lead developer as it builds world leading software for facial recognition. The company has hired Will Silva, a Brazilian IT...
A developer of targeted cancer therapies has outlined plans to become a public company and raise £7.5m. WAPG investee company BiVictriX Therapeutics has revealed its intention to apply for admission to the London Stock Exchange's AIM. BiVictriX is proposing to raise £7.5m, before expenses, by way of...
SurePulse Medical Ltd, a medical device company based in Nottingham, U.K., has announced today that it has received US FDA 510(k) clearance for its SurePulse VS Newborn Heart Rate Monitor. The wireless SurePulse VS is specifically designed to be used straight after birth in vulnerable newborn...
Charnwood Molecular, a leading UK-based pre-clinical discovery CRO serving the global pharmaceutical and biotechnology market, has added a range of new solid-state capabilities to its portfolio through a new collaborative partnership with Barcelona-based Solitek. The sector-leading expertise and technology development within Solitek combines an excellent understanding...
NanoSyrinx has raised a further £6.2m of seed financing, co-led by incoming Octopus Ventures and existing investor M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of Merck KGaA. Previous investors BioCity and the UK Innovation & Science Seed Fund (UKI2S) joined the funding...
WAPG's MediCity Nottingham based NuVision Biotherapies has come up with a product, which helps to heal eye injuries efficiently and wants to revolutionise the treatment of other wounds. The company recently picked up £1.8 million funding. This is the fourth fundraising round secured by NuVision...
WOMEN can now buy a contraceptive pill over the counter without a prescription following a consultation with a pharmacist after the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) today granted a licence to Maxwellia’s Lovima®. This reclassification of the daily progestogen-only pill is one of the...
Research published today has demonstrated the viability of 3D-printed tissue scaffolds that harmlessly degrade while promoting tissue regeneration following implantation. The scaffolds showed highly promising tissue-healing performance, including the ability to support cell migration, the ‘ingrowth’ of tissues, and revascularisation (blood vessel growth). Professor Andrew Dove, from...
A company, which has played a vital role in the fight against COVID-19, has received a Queen’s Award for Enterprise in International Trade. Absolute Antibody, based at the Wilton Centre, a WAPG site near Redcar, was told 14 months ago that it was being given the...
6 life science companies from the West Midlands and 6 from the East Midlands were delighted to be selected as winners at yesterday’s Medilink Midlands Business Awards, which saw over 130 businesspeople from life science companies across the region and beyond come together online to...